Calcium in PDB 2ozr: MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Protein crystallography data
The structure of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid, PDB code: 2ozr
was solved by
A.R.Johnson,
A.G.Pavlovsky,
D.F.Ortwine,
F.Prior,
C.-F.Man,
D.A.Bornemeier,
C.A.Banotai,
W.T.Mueller,
P.Mcconnell,
C.H.Yan,
V.Baragi,
C.Lesch,
W.H.Roark,
J.J.Lie,
V.Fasquelle,
M.Wilson,
D.Robertson,
K.Datta,
R.Guzman,
H.-K.Han,
R.D.Dyer,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.00 /
2.30
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
161.836,
71.974,
138.130,
90.00,
124.59,
90.00
|
R / Rfree (%)
|
24.8 /
34
|
Other elements in 2ozr:
The structure of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid also contains other interesting chemical elements:
Calcium Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
20;
Page 3, Binding sites: 21 -
24;
Binding sites:
The binding sites of Calcium atom in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
(pdb code 2ozr). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 24 binding sites of Calcium where determined in the
MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid, PDB code: 2ozr:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Calcium binding site 1 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 1 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca4003
b:18.2
occ:1.00
|
OE2
|
A:GLU184
|
2.2
|
18.3
|
1.0
|
OD2
|
A:ASP181
|
2.3
|
16.0
|
1.0
|
O
|
A:GLY159
|
2.3
|
21.7
|
1.0
|
O
|
A:SER161
|
2.3
|
23.7
|
1.0
|
O
|
A:LEU163
|
2.4
|
21.5
|
1.0
|
OD1
|
A:ASP158
|
2.6
|
24.4
|
1.0
|
CG
|
A:ASP181
|
3.4
|
15.2
|
1.0
|
C
|
A:SER161
|
3.5
|
23.5
|
1.0
|
CD
|
A:GLU184
|
3.5
|
18.3
|
1.0
|
C
|
A:LEU163
|
3.5
|
21.4
|
1.0
|
C
|
A:GLY159
|
3.5
|
22.1
|
1.0
|
CG
|
A:ASP158
|
3.6
|
23.8
|
1.0
|
N
|
A:SER161
|
3.9
|
23.0
|
1.0
|
C
|
A:PRO160
|
3.9
|
22.9
|
1.0
|
N
|
A:LEU163
|
3.9
|
22.3
|
1.0
|
CB
|
A:ASP181
|
4.2
|
14.9
|
1.0
|
OD2
|
A:ASP158
|
4.2
|
25.7
|
1.0
|
O
|
A:PRO160
|
4.2
|
23.0
|
1.0
|
N
|
A:GLY159
|
4.2
|
22.4
|
1.0
|
CA
|
A:SER161
|
4.2
|
23.4
|
1.0
|
N
|
A:ASP158
|
4.2
|
22.4
|
1.0
|
CA
|
A:LEU163
|
4.2
|
22.1
|
1.0
|
OE1
|
A:GLU184
|
4.3
|
19.3
|
1.0
|
OD1
|
A:ASP181
|
4.3
|
15.0
|
1.0
|
C
|
A:ASP158
|
4.3
|
22.6
|
1.0
|
C
|
A:GLY162
|
4.3
|
22.6
|
1.0
|
CA
|
A:PRO160
|
4.3
|
22.6
|
1.0
|
N
|
A:PRO160
|
4.4
|
22.1
|
1.0
|
CG
|
A:GLU184
|
4.4
|
17.3
|
1.0
|
N
|
A:GLY162
|
4.4
|
23.2
|
1.0
|
N
|
A:LEU164
|
4.5
|
20.8
|
1.0
|
CA
|
A:GLY159
|
4.5
|
22.1
|
1.0
|
CA
|
A:GLY162
|
4.6
|
22.9
|
1.0
|
CA
|
A:ASP158
|
4.6
|
22.8
|
1.0
|
CB
|
A:ASP158
|
4.7
|
23.0
|
1.0
|
O
|
A:ASP158
|
4.7
|
23.2
|
1.0
|
CB
|
A:LEU163
|
4.7
|
22.3
|
1.0
|
CA
|
A:LEU164
|
4.7
|
20.1
|
1.0
|
O
|
A:GLY162
|
4.9
|
22.8
|
1.0
|
CB
|
A:PHE157
|
5.0
|
21.3
|
1.0
|
|
Calcium binding site 2 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 2 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca4004
b:28.4
occ:1.00
|
O
|
A:GLY175
|
2.2
|
24.5
|
1.0
|
O
|
A:HOH4115
|
2.3
|
25.1
|
1.0
|
O
|
A:ASP141
|
2.3
|
19.3
|
1.0
|
O
|
A:ASN173
|
2.4
|
30.4
|
1.0
|
O
|
A:HOH4016
|
2.5
|
22.9
|
1.0
|
OD1
|
A:ASP177
|
2.6
|
18.8
|
1.0
|
C
|
A:GLY175
|
3.4
|
24.6
|
1.0
|
C
|
A:ASP141
|
3.5
|
19.6
|
1.0
|
CG
|
A:ASP177
|
3.5
|
18.9
|
1.0
|
C
|
A:ASN173
|
3.6
|
30.5
|
1.0
|
N
|
A:GLY175
|
3.9
|
27.3
|
1.0
|
C
|
A:TYR174
|
3.9
|
28.5
|
1.0
|
OD2
|
A:ASP177
|
3.9
|
19.7
|
1.0
|
O
|
A:ALA140
|
4.1
|
21.0
|
1.0
|
CA
|
A:GLY175
|
4.2
|
25.6
|
1.0
|
N
|
A:ASP177
|
4.2
|
19.6
|
1.0
|
O
|
A:TYR174
|
4.2
|
28.3
|
1.0
|
CA
|
A:ASP141
|
4.2
|
20.3
|
1.0
|
O
|
A:HOH4043
|
4.2
|
25.1
|
1.0
|
N
|
A:GLY176
|
4.3
|
23.2
|
1.0
|
CA
|
A:TYR174
|
4.4
|
29.3
|
1.0
|
N
|
A:TYR174
|
4.4
|
30.0
|
1.0
|
O
|
A:GLY171
|
4.5
|
30.4
|
1.0
|
O
|
A:HOH4121
|
4.5
|
14.0
|
1.0
|
N
|
A:ILE142
|
4.5
|
18.8
|
1.0
|
CA
|
A:GLY176
|
4.6
|
21.8
|
1.0
|
C
|
A:GLY176
|
4.6
|
20.9
|
1.0
|
N
|
A:MET143
|
4.6
|
16.7
|
1.0
|
CB
|
A:ASP177
|
4.7
|
18.4
|
1.0
|
CA
|
A:ASN173
|
4.7
|
30.9
|
1.0
|
CA
|
A:ILE142
|
4.7
|
17.7
|
1.0
|
N
|
A:ASN173
|
4.8
|
31.2
|
1.0
|
CA
|
A:ASP177
|
4.8
|
18.6
|
1.0
|
CG
|
A:MET143
|
4.9
|
17.7
|
1.0
|
CH2
|
A:TRP92
|
5.0
|
34.0
|
1.0
|
|
Calcium binding site 3 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 3 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca4005
b:41.8
occ:1.00
|
OD2
|
A:ASP107
|
2.1
|
16.8
|
1.0
|
O
|
A:GLU184
|
2.3
|
16.4
|
1.0
|
O
|
A:HOH4088
|
2.4
|
29.8
|
1.0
|
O
|
A:ASP182
|
2.6
|
17.0
|
1.0
|
OD1
|
A:ASP182
|
2.6
|
14.6
|
1.0
|
CG
|
A:ASP107
|
3.1
|
16.8
|
1.0
|
C
|
A:ASP182
|
3.4
|
16.6
|
1.0
|
OD1
|
A:ASP107
|
3.5
|
17.5
|
1.0
|
C
|
A:GLU184
|
3.5
|
17.1
|
1.0
|
CG
|
A:ASP182
|
3.6
|
16.4
|
1.0
|
OG1
|
A:THR105
|
3.6
|
13.7
|
1.0
|
CA
|
A:ASP182
|
3.8
|
16.2
|
1.0
|
CD1
|
A:TRP186
|
3.9
|
17.0
|
1.0
|
O
|
G:HOH4109
|
4.0
|
19.6
|
1.0
|
O
|
G:HOH4113
|
4.0
|
5.7
|
1.0
|
CB
|
A:ASP182
|
4.1
|
15.8
|
1.0
|
N
|
A:GLU184
|
4.3
|
17.3
|
1.0
|
CA
|
A:THR185
|
4.3
|
17.8
|
1.0
|
N
|
A:THR185
|
4.4
|
17.5
|
1.0
|
N
|
A:ASP183
|
4.4
|
16.7
|
1.0
|
CB
|
A:ASP107
|
4.5
|
15.7
|
1.0
|
NE1
|
A:TRP186
|
4.5
|
16.5
|
1.0
|
N
|
A:TRP186
|
4.5
|
18.6
|
1.0
|
CA
|
A:GLU184
|
4.5
|
17.1
|
1.0
|
C
|
A:ASP183
|
4.5
|
17.0
|
1.0
|
OD2
|
A:ASP182
|
4.6
|
17.0
|
1.0
|
CD
|
A:PRO106
|
4.6
|
14.3
|
1.0
|
CA
|
A:ASP183
|
4.7
|
17.0
|
1.0
|
CG
|
A:TRP186
|
4.9
|
17.7
|
1.0
|
CB
|
A:THR105
|
4.9
|
13.5
|
1.0
|
C
|
A:THR185
|
5.0
|
18.3
|
1.0
|
|
Calcium binding site 4 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 4 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca4008
b:19.4
occ:1.00
|
OD2
|
B:ASP181
|
2.2
|
15.9
|
1.0
|
O
|
B:LEU163
|
2.3
|
21.1
|
1.0
|
O
|
B:SER161
|
2.4
|
23.3
|
1.0
|
O
|
B:GLY159
|
2.4
|
22.1
|
1.0
|
OE2
|
B:GLU184
|
2.4
|
16.8
|
1.0
|
OD1
|
B:ASP158
|
2.4
|
24.2
|
1.0
|
CG
|
B:ASP181
|
3.4
|
14.6
|
1.0
|
C
|
B:LEU163
|
3.5
|
21.2
|
1.0
|
C
|
B:SER161
|
3.5
|
23.2
|
1.0
|
C
|
B:GLY159
|
3.6
|
22.3
|
1.0
|
CD
|
B:GLU184
|
3.6
|
17.7
|
1.0
|
CG
|
B:ASP158
|
3.6
|
23.4
|
1.0
|
N
|
B:LEU163
|
3.8
|
22.2
|
1.0
|
C
|
B:PRO160
|
4.1
|
23.0
|
1.0
|
CB
|
B:ASP181
|
4.1
|
14.5
|
1.0
|
N
|
B:SER161
|
4.1
|
22.9
|
1.0
|
CA
|
B:LEU163
|
4.1
|
21.8
|
1.0
|
N
|
B:GLY159
|
4.1
|
22.5
|
1.0
|
N
|
B:ASP158
|
4.2
|
22.4
|
1.0
|
C
|
B:GLY162
|
4.2
|
22.5
|
1.0
|
O
|
B:PRO160
|
4.2
|
23.4
|
1.0
|
OD2
|
B:ASP158
|
4.3
|
26.5
|
1.0
|
C
|
B:ASP158
|
4.3
|
22.8
|
1.0
|
OE1
|
B:GLU184
|
4.3
|
18.2
|
1.0
|
OD1
|
B:ASP181
|
4.3
|
14.3
|
1.0
|
CA
|
B:SER161
|
4.4
|
23.0
|
1.0
|
N
|
B:GLY162
|
4.4
|
23.0
|
1.0
|
CA
|
B:GLY159
|
4.5
|
22.4
|
1.0
|
N
|
B:PRO160
|
4.5
|
22.3
|
1.0
|
CA
|
B:GLY162
|
4.5
|
22.6
|
1.0
|
CB
|
B:LEU163
|
4.5
|
21.7
|
1.0
|
N
|
B:LEU164
|
4.5
|
20.6
|
1.0
|
CA
|
B:PRO160
|
4.5
|
22.6
|
1.0
|
CA
|
B:ASP158
|
4.6
|
22.8
|
1.0
|
CG
|
B:GLU184
|
4.7
|
17.4
|
1.0
|
CB
|
B:ASP158
|
4.7
|
22.8
|
1.0
|
O
|
B:ASP158
|
4.7
|
23.0
|
1.0
|
O
|
B:HOH4066
|
4.8
|
26.6
|
1.0
|
CA
|
B:LEU164
|
4.8
|
19.9
|
1.0
|
CB
|
B:PHE157
|
4.8
|
21.3
|
1.0
|
O
|
B:GLY162
|
4.8
|
22.9
|
1.0
|
|
Calcium binding site 5 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 5 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca4009
b:28.9
occ:1.00
|
O
|
B:ASP141
|
2.3
|
19.0
|
1.0
|
O
|
B:GLY175
|
2.4
|
24.0
|
1.0
|
O
|
B:ASN173
|
2.4
|
29.9
|
1.0
|
O
|
B:HOH4017
|
2.5
|
37.9
|
1.0
|
O
|
B:HOH4097
|
2.5
|
12.0
|
1.0
|
OD1
|
B:ASP177
|
2.6
|
19.1
|
1.0
|
C
|
B:ASP141
|
3.5
|
19.4
|
1.0
|
C
|
B:GLY175
|
3.5
|
24.2
|
1.0
|
CG
|
B:ASP177
|
3.5
|
18.8
|
1.0
|
C
|
B:ASN173
|
3.5
|
30.0
|
1.0
|
C
|
B:TYR174
|
3.8
|
27.9
|
1.0
|
O
|
B:TYR174
|
3.9
|
27.4
|
1.0
|
N
|
B:GLY175
|
4.0
|
26.7
|
1.0
|
OD2
|
B:ASP177
|
4.0
|
18.9
|
1.0
|
N
|
B:ASP177
|
4.2
|
19.5
|
1.0
|
O
|
B:ALA140
|
4.2
|
21.1
|
1.0
|
CA
|
B:GLY175
|
4.2
|
25.2
|
1.0
|
CA
|
B:TYR174
|
4.3
|
28.7
|
1.0
|
CA
|
B:ASP141
|
4.3
|
20.0
|
1.0
|
N
|
B:TYR174
|
4.3
|
29.5
|
1.0
|
O
|
B:HOH4055
|
4.3
|
22.5
|
1.0
|
N
|
B:GLY176
|
4.4
|
23.1
|
1.0
|
N
|
B:ILE142
|
4.5
|
18.3
|
1.0
|
N
|
B:MET143
|
4.6
|
16.7
|
1.0
|
CA
|
B:ASN173
|
4.6
|
30.5
|
1.0
|
CA
|
B:GLY176
|
4.6
|
21.9
|
1.0
|
O
|
B:GLY171
|
4.6
|
30.0
|
1.0
|
C
|
B:GLY176
|
4.7
|
20.8
|
1.0
|
CA
|
B:ILE142
|
4.7
|
17.7
|
1.0
|
CB
|
B:ASP177
|
4.7
|
18.1
|
1.0
|
N
|
B:ASN173
|
4.7
|
30.6
|
1.0
|
CA
|
B:ASP177
|
4.8
|
18.4
|
1.0
|
CG
|
B:MET143
|
4.9
|
17.9
|
1.0
|
CH2
|
B:TRP92
|
5.0
|
34.0
|
1.0
|
|
Calcium binding site 6 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 6 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca4010
b:44.4
occ:1.00
|
OD2
|
B:ASP107
|
2.1
|
17.7
|
1.0
|
O
|
B:GLU184
|
2.4
|
16.8
|
1.0
|
O
|
B:HOH4018
|
2.4
|
26.1
|
1.0
|
OD1
|
B:ASP182
|
2.6
|
12.5
|
1.0
|
O
|
B:ASP182
|
2.6
|
16.4
|
1.0
|
CG
|
B:ASP107
|
3.1
|
16.7
|
1.0
|
OD1
|
B:ASP107
|
3.5
|
17.6
|
1.0
|
C
|
B:ASP182
|
3.5
|
16.3
|
1.0
|
OG1
|
B:THR105
|
3.6
|
13.5
|
1.0
|
CG
|
B:ASP182
|
3.6
|
15.1
|
1.0
|
C
|
B:GLU184
|
3.6
|
17.0
|
1.0
|
O
|
H:HOH4046
|
3.8
|
13.6
|
1.0
|
CA
|
B:ASP182
|
4.0
|
15.7
|
1.0
|
CD1
|
B:TRP186
|
4.1
|
16.2
|
1.0
|
CB
|
B:ASP182
|
4.3
|
15.4
|
1.0
|
N
|
B:GLU184
|
4.3
|
17.2
|
1.0
|
CB
|
B:ASP107
|
4.3
|
15.6
|
1.0
|
CA
|
B:THR185
|
4.4
|
17.5
|
1.0
|
O
|
H:HOH4134
|
4.5
|
34.5
|
1.0
|
N
|
B:THR185
|
4.5
|
17.2
|
1.0
|
OD2
|
B:ASP182
|
4.5
|
16.4
|
1.0
|
N
|
B:ASP183
|
4.5
|
16.6
|
1.0
|
N
|
B:TRP186
|
4.6
|
18.3
|
1.0
|
CD
|
B:PRO106
|
4.6
|
14.2
|
1.0
|
CA
|
B:GLU184
|
4.6
|
17.1
|
1.0
|
C
|
B:ASP183
|
4.6
|
17.2
|
1.0
|
NE1
|
B:TRP186
|
4.7
|
16.7
|
1.0
|
CA
|
B:ASP183
|
4.8
|
16.9
|
1.0
|
CB
|
B:THR105
|
4.9
|
13.6
|
1.0
|
|
Calcium binding site 7 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 7 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 7 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca4013
b:17.8
occ:1.00
|
O
|
C:GLY159
|
2.2
|
21.6
|
1.0
|
OE2
|
C:GLU184
|
2.3
|
16.3
|
1.0
|
O
|
C:SER161
|
2.3
|
23.1
|
1.0
|
OD1
|
C:ASP158
|
2.3
|
23.6
|
1.0
|
OD2
|
C:ASP181
|
2.3
|
17.5
|
1.0
|
O
|
C:LEU163
|
2.4
|
19.9
|
1.0
|
C
|
C:SER161
|
3.4
|
23.0
|
1.0
|
CG
|
C:ASP158
|
3.4
|
23.5
|
1.0
|
C
|
C:GLY159
|
3.4
|
22.0
|
1.0
|
CG
|
C:ASP181
|
3.5
|
15.2
|
1.0
|
CD
|
C:GLU184
|
3.5
|
17.1
|
1.0
|
C
|
C:LEU163
|
3.6
|
21.1
|
1.0
|
N
|
C:SER161
|
3.8
|
22.9
|
1.0
|
C
|
C:PRO160
|
3.9
|
22.7
|
1.0
|
OD2
|
C:ASP158
|
3.9
|
25.0
|
1.0
|
N
|
C:LEU163
|
4.0
|
21.9
|
1.0
|
N
|
C:GLY159
|
4.1
|
22.3
|
1.0
|
CA
|
C:SER161
|
4.1
|
22.9
|
1.0
|
CB
|
C:ASP181
|
4.2
|
14.7
|
1.0
|
O
|
C:PRO160
|
4.2
|
23.0
|
1.0
|
N
|
C:ASP158
|
4.3
|
21.8
|
1.0
|
C
|
C:GLY162
|
4.3
|
22.3
|
1.0
|
CA
|
C:LEU163
|
4.3
|
21.5
|
1.0
|
OE1
|
C:GLU184
|
4.3
|
18.0
|
1.0
|
C
|
C:ASP158
|
4.3
|
22.4
|
1.0
|
CA
|
C:PRO160
|
4.3
|
22.6
|
1.0
|
N
|
C:PRO160
|
4.3
|
22.4
|
1.0
|
N
|
C:GLY162
|
4.3
|
22.9
|
1.0
|
CA
|
C:GLY159
|
4.4
|
21.9
|
1.0
|
OD1
|
C:ASP181
|
4.4
|
14.7
|
1.0
|
CG
|
C:GLU184
|
4.5
|
16.8
|
1.0
|
CA
|
C:GLY162
|
4.5
|
22.6
|
1.0
|
CB
|
C:ASP158
|
4.6
|
22.5
|
1.0
|
CA
|
C:ASP158
|
4.6
|
22.3
|
1.0
|
N
|
C:LEU164
|
4.6
|
20.9
|
1.0
|
CB
|
C:LEU163
|
4.7
|
21.5
|
1.0
|
CA
|
C:LEU164
|
4.8
|
20.6
|
1.0
|
O
|
C:ASP158
|
4.8
|
22.4
|
1.0
|
O
|
C:GLY162
|
4.9
|
22.6
|
1.0
|
|
Calcium binding site 8 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 8 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 8 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca4014
b:26.2
occ:1.00
|
O
|
C:ASP141
|
2.2
|
18.8
|
1.0
|
O
|
C:HOH4147
|
2.3
|
22.8
|
1.0
|
O
|
C:HOH4020
|
2.3
|
19.1
|
1.0
|
O
|
C:ASN173
|
2.4
|
30.6
|
1.0
|
O
|
C:GLY175
|
2.4
|
24.8
|
1.0
|
OD1
|
C:ASP177
|
2.5
|
19.4
|
1.0
|
C
|
C:ASP141
|
3.4
|
18.9
|
1.0
|
CG
|
C:ASP177
|
3.4
|
18.6
|
1.0
|
C
|
C:GLY175
|
3.5
|
24.7
|
1.0
|
C
|
C:ASN173
|
3.6
|
30.4
|
1.0
|
OD2
|
C:ASP177
|
3.8
|
18.1
|
1.0
|
C
|
C:TYR174
|
4.0
|
28.6
|
1.0
|
O
|
C:ALA140
|
4.1
|
20.9
|
1.0
|
O
|
C:TYR174
|
4.1
|
28.4
|
1.0
|
N
|
C:GLY175
|
4.1
|
27.2
|
1.0
|
N
|
C:ASP177
|
4.2
|
19.6
|
1.0
|
O
|
C:HOH4161
|
4.2
|
23.4
|
1.0
|
CA
|
C:ASP141
|
4.2
|
19.6
|
1.0
|
O
|
C:HOH4126
|
4.3
|
44.6
|
1.0
|
N
|
C:ILE142
|
4.3
|
18.1
|
1.0
|
CA
|
C:GLY175
|
4.4
|
25.9
|
1.0
|
CA
|
C:TYR174
|
4.4
|
29.4
|
1.0
|
N
|
C:TYR174
|
4.4
|
29.9
|
1.0
|
CA
|
C:ILE142
|
4.5
|
17.3
|
1.0
|
N
|
C:GLY176
|
4.5
|
23.2
|
1.0
|
O
|
C:HOH4144
|
4.5
|
24.5
|
1.0
|
O
|
C:GLY171
|
4.5
|
29.8
|
1.0
|
CA
|
C:ASN173
|
4.6
|
30.8
|
1.0
|
N
|
C:MET143
|
4.6
|
16.4
|
1.0
|
N
|
C:ASN173
|
4.6
|
30.6
|
1.0
|
CB
|
C:ASP177
|
4.6
|
18.1
|
1.0
|
CA
|
C:GLY176
|
4.6
|
22.3
|
1.0
|
C
|
C:GLY176
|
4.6
|
21.0
|
1.0
|
CA
|
C:ASP177
|
4.8
|
18.2
|
1.0
|
CG
|
C:MET143
|
4.8
|
17.1
|
1.0
|
C
|
C:PRO172
|
4.9
|
30.6
|
1.0
|
|
Calcium binding site 9 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 9 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 9 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca4015
b:36.2
occ:1.00
|
OD2
|
C:ASP107
|
2.4
|
17.3
|
1.0
|
O
|
C:GLU184
|
2.4
|
17.8
|
1.0
|
O
|
C:HOH4150
|
2.4
|
21.1
|
1.0
|
O
|
C:ASP182
|
2.6
|
16.5
|
1.0
|
OD1
|
C:ASP182
|
2.9
|
15.2
|
1.0
|
CG
|
C:ASP107
|
3.1
|
17.1
|
1.0
|
OD1
|
C:ASP107
|
3.1
|
18.6
|
1.0
|
C
|
C:ASP182
|
3.4
|
16.3
|
1.0
|
C
|
C:GLU184
|
3.6
|
17.5
|
1.0
|
OG1
|
C:THR105
|
3.9
|
12.7
|
1.0
|
CG
|
C:ASP182
|
3.9
|
16.2
|
1.0
|
CA
|
C:ASP182
|
3.9
|
16.2
|
1.0
|
CD1
|
C:TRP186
|
4.2
|
16.8
|
1.0
|
CA
|
C:THR185
|
4.3
|
17.7
|
1.0
|
N
|
C:ASP183
|
4.3
|
16.2
|
1.0
|
CB
|
C:ASP182
|
4.4
|
16.1
|
1.0
|
N
|
C:THR185
|
4.4
|
17.5
|
1.0
|
C
|
C:ASP183
|
4.4
|
16.8
|
1.0
|
N
|
C:GLU184
|
4.4
|
16.9
|
1.0
|
CB
|
C:ASP107
|
4.5
|
16.8
|
1.0
|
CA
|
C:ASP183
|
4.6
|
16.5
|
1.0
|
CD
|
C:PRO106
|
4.6
|
14.3
|
1.0
|
CA
|
C:GLU184
|
4.7
|
17.2
|
1.0
|
N
|
C:TRP186
|
4.7
|
18.4
|
1.0
|
NE1
|
C:TRP186
|
4.8
|
16.4
|
1.0
|
O
|
C:ASP183
|
4.8
|
17.5
|
1.0
|
O
|
C:HOH4155
|
4.8
|
30.5
|
1.0
|
OD2
|
C:ASP182
|
4.9
|
16.9
|
1.0
|
|
Calcium binding site 10 out
of 24 in 2ozr
Go back to
Calcium Binding Sites List in 2ozr
Calcium binding site 10 out
of 24 in the MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 10 of MMP13 Catalytic Domain Complexed with 4-{[1-Methyl-2,4-Dioxo-6-(3- Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2H)-Yl]Methyl}Benzoic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca4018
b:20.7
occ:1.00
|
O
|
D:LEU163
|
2.3
|
21.0
|
1.0
|
OE2
|
D:GLU184
|
2.3
|
19.2
|
1.0
|
O
|
D:SER161
|
2.3
|
23.1
|
1.0
|
OD2
|
D:ASP181
|
2.3
|
16.6
|
1.0
|
O
|
D:GLY159
|
2.4
|
21.9
|
1.0
|
OD1
|
D:ASP158
|
2.4
|
25.2
|
1.0
|
C
|
D:SER161
|
3.4
|
23.3
|
1.0
|
CG
|
D:ASP181
|
3.4
|
15.1
|
1.0
|
C
|
D:LEU163
|
3.4
|
21.3
|
1.0
|
CG
|
D:ASP158
|
3.5
|
23.8
|
1.0
|
CD
|
D:GLU184
|
3.6
|
18.5
|
1.0
|
C
|
D:GLY159
|
3.6
|
22.4
|
1.0
|
N
|
D:SER161
|
3.9
|
23.4
|
1.0
|
N
|
D:LEU163
|
3.9
|
21.8
|
1.0
|
OD2
|
D:ASP158
|
4.0
|
25.8
|
1.0
|
C
|
D:PRO160
|
4.0
|
23.0
|
1.0
|
CB
|
D:ASP181
|
4.1
|
14.6
|
1.0
|
N
|
D:GLY159
|
4.1
|
22.4
|
1.0
|
CA
|
D:LEU163
|
4.2
|
21.9
|
1.0
|
CA
|
D:SER161
|
4.2
|
23.4
|
1.0
|
C
|
D:GLY162
|
4.2
|
22.1
|
1.0
|
O
|
D:PRO160
|
4.3
|
22.8
|
1.0
|
N
|
D:ASP158
|
4.3
|
22.3
|
1.0
|
N
|
D:GLY162
|
4.3
|
23.1
|
1.0
|
OD1
|
D:ASP181
|
4.4
|
14.3
|
1.0
|
OE1
|
D:GLU184
|
4.4
|
19.4
|
1.0
|
CG
|
D:GLU184
|
4.4
|
17.5
|
1.0
|
C
|
D:ASP158
|
4.4
|
22.7
|
1.0
|
CA
|
D:GLY159
|
4.4
|
22.2
|
1.0
|
N
|
D:LEU164
|
4.5
|
20.8
|
1.0
|
CB
|
D:LEU163
|
4.5
|
21.6
|
1.0
|
CA
|
D:GLY162
|
4.5
|
22.7
|
1.0
|
N
|
D:PRO160
|
4.5
|
22.7
|
1.0
|
CA
|
D:PRO160
|
4.5
|
22.8
|
1.0
|
CA
|
D:LEU164
|
4.7
|
20.3
|
1.0
|
CB
|
D:ASP158
|
4.7
|
23.0
|
1.0
|
O
|
D:GLY162
|
4.7
|
22.4
|
1.0
|
CA
|
D:ASP158
|
4.7
|
22.8
|
1.0
|
O
|
D:ASP158
|
5.0
|
22.5
|
1.0
|
|
Reference:
A.R.Johnson,
A.G.Pavlovsky,
D.F.Ortwine,
F.Prior,
C.F.Man,
D.A.Bornemeier,
C.A.Banotai,
W.T.Mueller,
P.Mcconnell,
C.Yan,
V.Baragi,
C.Lesch,
W.H.Roark,
M.Wilson,
K.Datta,
R.Guzman,
H.K.Han,
R.D.Dyer.
Discovery and Characterization of A Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo Without Joint Fibroplasia Side Effects. J.Biol.Chem. V. 282 27781 2007.
ISSN: ISSN 0021-9258
PubMed: 17623656
DOI: 10.1074/JBC.M703286200
Page generated: Fri Jul 12 14:55:08 2024
|